The Alzheimer’s Drug Discovery Foundation will be moderating a session, “Beyond Amyloid and Tau: Emerging Solutions,” at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, which will be held November 29th through December 2nd at the Hilton Union Square in San Francisco, California.

Related posts:

  1. ‘Zombie cells’ in the body tied to aging may actually help heal tissue damage
  2. Cellular senescence and senolytics: the path to the clinic
  3. A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice
  4. Global Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape